GSK plc (GSK)

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

As of November 3, 2026, GSK plc (GSK) stock edged lower to $48.91, down 0.44% (-$0.22) versus the previous close. On the day, shares have traded between $48.84 and $49.56. That puts GSK in the lower third of its 52-week range of $45.81 to $61.70. GSK plc carries a market capitalization of roughly $99.19 billion, with about 1.47 million shares changing hands.

Latest GSK news

• The U.S. Stocks Quietly Winning the Chinese Drug BoomYahoo Finance· Nov 3, 10:26 AM ET
• Buy Moderna Stock Before Q3 Earnings? Here's What to KnowYahoo Finance· Nov 2, 11:14 AM ET
• Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026Yahoo Finance· Nov 2, 8:00 AM ETPBC
• GSK (LSE:GSK) Wins FDA Nod For Jemperli As ESMO Data Builds Oncology CaseYahoo Finance· Nov 1, 6:15 AM ET
• GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Yahoo Finance· Oct 29, 11:23 AM ET
• Chiesi Group appoints Paolo Paoletti to its Board of DirectorsYahoo Finance· Oct 29, 6:01 AM ET
• GSK (LSE:GSK) Shares Dropped, So What Is Behind The Latest Attention?Yahoo Finance· Oct 29, 4:23 AM ET
• Genmab Stock Surges to Record High After Stunning Cancer Drug ResultsYahoo Finance· Oct 28, 4:19 PM ET

Source: Yahoo Finance RSS · Updated November 3, 2026

Want GSK headlines, alerts and AI research in one place? Create a free account →

• $NVAX i wonder why $GSK doesnt buy Novavax flu/19 combo and doesn't develop their combo as the back up plan and make the money on the novavax combo meanwhile. because they are in phase 1 which will end next year. even if they should pay some minimal payment like $1.2B to n…

  @Pissed_of_retards2· Oct 30, 12:37 PM ET

• $SLS $GSK $HGSI I have been trading in the biotechnology sector for over 30 years now. My biggest hit in biotechnology sector was HGSI during the peak of financial collapse. HGSI was trading under a dollar left for dead and awaiting results for its phase 3 data for its Drug Be…

  @Johnmtnb2018· Oct 30, 11:19 AM ET· Bullish

• $GSK Suddenly GSK looks very attractive.

  @IndyOne· Oct 30, 6:09 AM ET· Bullish

• @Corona76ers fair point on Blenrep imo, that REMS for ocular toxicity is real and it is a separate myeloma drug. the one in this post is different, neladalkib is an ALK lung drug and the brain data is what caught my eye into Nov 27. 32% intracranial response in measurable brai…

  @BiotechSwings· Oct 29, 2:14 AM ET

• $GSK What is the cure for dementia worth these days? DOUBLE WOW, might make $MRNA look like child's play. And, I love Moderna. Fact check my posts from like October 2025 to August 2026. Looking for some place for Moderna money. This is one place. $MRK

  @IndyOne· Oct 28, 6:24 PM ET· Bullish

Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →